Table 3 Neonatal Morbidity and Mortality
| Â | 17-Hydroxyprogesterone Caproate | Placebo |
|---|---|---|
| Â | (N = 4) | (N = 8) |
Composite Neonatal Morbidity | 3 (75%) | 7 (87.5%) |
Perinatal Death | ||
   Stillbirth/Miscarriage | 0 | 0 |
   Neonatal Death | 1 (25%) | 1 (12.5%) |
Respiratory Distress Syndrome | 3 (75%) | 7 (87.5%) |
Sepsis, Culture-Proven | 0 | 0 |
Pneumonia | 0 | 0 |
Intraventricular hemorrhage, Grade 3 or 4 | 2 (50%) | 0 |
Periventricular Leukomalacia | 0 | 0 |
Necrotizing Enterocolitis | 1 (25%) | 0 |